We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
-4.5%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$508M
AUM Growth
+$83.8M
Cap. Flow
+$371M
Cap. Flow %
73%
Top 10 Hldgs %
48.66%
Holding
368
New
95
Increased
39
Reduced
35
Closed
113

Top Buys

Rank Stock Value
1
SMCI icon
Super Micro Computer
SMCI
+$25.5M
2
MSTR icon
Strategy Inc
MSTR
+$22.3M
3
IMCR icon
Immunocore
IMCR
+$13M
4
IBIT icon
iShares Bitcoin Trust
IBIT
+$11.2M
5
BABA icon
Alibaba
BABA
+$9.93M

Sector Composition

Rank Sector Weight
1 Technology 24.85%
2 Financials 17.41%
3 Communication Services 10.98%
4 Consumer Discretionary 8.69%
5 Healthcare 7.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RND
126
First Trust Bloomberg R&D Leaders ETF
RND
$7.72M
$337K 0.07%
+15,000
New +$320K
DELL icon
127
Dell
DELL
$273B
$335K 0.07%
2,427
-1,580
-39% -$212K
SMR icon
128
NuScale Power
SMR
$2.85B
$326K 0.06%
+27,900
New +$199K
RFAIU
129
RF Acquisition Corp II Unit
RFAIU
$325K 0.06%
+32,295
New +$325K
GUSH icon
130
Direxion Daily S&P Oil & Gas Exp. & Prod. Bull 2X ETF
GUSH
$238M
$313K 0.06%
8,834
GRAL
131
GRAIL Inc
GRAL
$2.88B
$307K 0.06%
+20,000
New +$324K
META icon
132
Meta Platforms (Facebook)
META
$1.52T
$304K 0.06%
603
-10
-2% -$4.86K
GLD icon
133
SPDR Gold Trust
GLD
$132B
$273K 0.05%
+1,269
New +$274K
TMC icon
134
TMC The Metals Company
TMC
$1.61B
$270K 0.05%
200,000
+100,000
+100% +$153K
AXNX
135
DELISTED
Axonics, Inc. Common Stock
AXNX
$269K 0.05%
4,000
-12,000
-75% -$808K
FDMT icon
136
4D Molecular Therapeutics
FDMT
$540M
$262K 0.05%
+12,500
New +$314K
INBX icon
137
Inhibrx
INBX
$1.23B
$259K 0.05%
+18,263
New +$285K
FLNA
138
PUT
Filana Therapeutics
FLNA
$44.1M
$252K 0.05%
42,500
+2,500
+6% +$52.7K
NRGU icon
139
MicroSectors U.S. Big Oil 3x Leveraged ETNs due Feb 17 2045
NRGU
$21.1M
$237K 0.05%
474
-270
-36% -$152K
LIDR icon
140
AEye
LIDR
$51.4M
$223K 0.04%
114,200
-3
-0% -$6
ALIM
141
DELISTED
Alimera Sciences
ALIM
$211K 0.04%
+37,886
New +$135K
META icon
142
CALL
Meta Platforms (Facebook)
META
$1.52T
$197K 0.04%
+526,500
New +$256M
BNZI icon
143
Banzai International
BNZI
$7.16M
$189K 0.04%
111
NVAX icon
144
PUT
Novavax
NVAX
$1.26B
$169K 0.03%
+21,800
New +$219K
USARW
145
DELISTED
USA Rare Earth Inc Warrant
USARW
$160K 0.03%
1,690,756
GROY icon
146
Gold Royalty Corp
GROY
$600M
$157K 0.03%
111,578
SLAMW
147
DELISTED
Slam Corp. warrant
SLAMW
$154K 0.03%
617,889
-56,171
-8% -$9.91K
NFLX icon
148
CALL
Netflix
NFLX
$296B
$154K 0.03%
+860,000
New +$53.7M
SPY icon
149
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$780B
$150K 0.03%
500,000
-960,000
-66% -$502M
ZCAR
150
DELISTED
Zoomcar
ZCAR
$150K 0.03%
500

Similar funds

Cantor Fitzgerald's Q2 2024 Portfolio in Review

As of Q2 2024, Cantor Fitzgerald held 368 positions worth $508M, up 20% from $424M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Cantor Fitzgerald deployed $371M of net new capital in Q2 2024, opening 95 new positions and adding to 39 existing holdings. Its largest new stake was Super Micro Computer: 298,270 shares worth $24.4M.

By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 14% a quarter earlier, followed by Financials and Communication Services.

On the sell side, the largest reduction was ProShares UltraPro QQQ, an estimated $20.1M trimmed.

  • Cantor Fitzgerald's largest Q2 2024 buy was Super Micro Computer: 298,270 shares worth $24.4M.
  • Cantor Fitzgerald added most to Strategy Inc in Q2 2024, an estimated $22.3M increase.
  • Cantor Fitzgerald's biggest Q2 2024 reduction was ProShares UltraPro QQQ, cutting an estimated $20.1M.
  • Cantor Fitzgerald fully exited Inhibrx, Inc. Common Stock in Q2 2024, selling an estimated $4.88M.
  • Cantor Fitzgerald's ten largest holdings make up 49% of its $508M portfolio in Q2 2024.
  • Cantor Fitzgerald opened 95 new positions and closed 113 in Q2 2024.
  • Cantor Fitzgerald's portfolio value rose 20% quarter-over-quarter to $508M.

Based on Cantor Fitzgerald's 13F filing for Q2 2024, filed 14 Aug 2024.